{
  "actions": [
    {
      "acted_at": "2009-10-08", 
      "references": [
        {
          "reference": "CR E2487-2488", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2009-10-08", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2009-10-09", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3777-111", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "111", 
  "cosponsors": [
    {
      "district": "28", 
      "name": "Slaughter, Louise McIntosh", 
      "sponsored_at": "2010-02-02", 
      "state": "NY", 
      "thomas_id": "01069", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "4", 
      "name": "Taylor, Gene", 
      "sponsored_at": "2009-10-08", 
      "state": "MS", 
      "thomas_id": "01142", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2009-10-08", 
  "number": "3777", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to define the term \"first applicant\" for purposes of filing an abbreviated application for a new drug.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s1315-111", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Drug Price Competition Act of 2009", 
  "sponsor": {
    "district": "23", 
    "name": "Hastings, Alcee L.", 
    "state": "FL", 
    "thomas_id": "00511", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2009-10-08", 
  "subjects": [
    "Drug safety, medical device, and laboratory regulation", 
    "Health", 
    "Intellectual property", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2009-10-08", 
    "text": "Drug Price Competition Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to expand the definition of \"first applicant\" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant to submit a substantially complete application that contains and lawfully maintains a certification for such drug."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Drug Price Competition Act of 2009", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to define the term \"first applicant\" for purposes of filing an abbreviated application for a new drug.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-19T23:46:11-04:00"
}